Kunming Longjin Pharmaceutical Co Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kunming Longjin Pharmaceutical Co Ltd with three other
companies in this sector in China:
Star Pharmaceutical Limited
sales of 242.31 million Chinese Renmimbi [US$36.23 million]
Anhui Sunhere Pharmaceutical Excipients Co Ltd
(428.56 million Chinese Renmimbi [US$64.08 million]
of which 100%
was Pharmacy), and
Zhejiang Shouxiangu Pharmaceutical Co Ltd
(511.45 million Chinese Renmimbi [US$76.47 million]
of which 98%
was Manufacturing Industry).
Kunming Longjin Pharmaceutical Co Ltd reported sales of 335.98 million Chinese Renmimbi (US$50.24 million)
December of 2018.
increase of 10.4%
versus 2017, when the company's sales were 304.45 million Chinese Renmimbi.
This was the third consecutive year of growth at Kunming Longjin Pharmaceutical Co Ltd.